SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-284289
Filing Date
2023-11-28
Accepted
2023-11-28 16:14:33
Documents
14
Period of Report
2023-11-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d918010d8k.htm   iXBRL 8-K 33714
2 EX-10.1 d918010dex101.htm EX-10.1 8156
3 EX-10.2 d918010dex102.htm EX-10.2 26775
  Complete submission text file 0001193125-23-284289.txt   207063

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA harp-20231126.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20231126_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20231126_pre.xml EX-101.PRE 11713
8 EXTRACTED XBRL INSTANCE DOCUMENT d918010d8k_htm.xml XML 3486
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 231446558
SIC: 2836 Biological Products, (No Diagnostic Substances)